Both medications share similar discontinuation rates, with about 48% of patients stopping due to gastrointestinal issues
The FDA might require post-approval studies or risk management plans
The results youll see, Dr
You may be eligible to participate if you are 18 or older and have: Been diagnosed with painful diabetic peripheral neuropathy or report pain that is consistent with a diagnosis and has been going on for at least three months Been diagnosed with type 2 diabetes at least six months prior to screening Been taking any diabetes or pain medications that you are using regularly for at least three months prior to screening An A1C of 6.0-10.5% at screening A BMI greater than 25 Women who are pregnant, breastfeeding, or planning to become pregnant are not eligible to participate
Our Service Areas: Orchard Park, NY West Seneca, NY Hamburg, NY Lackawanna, NY Blasdell, NY East Aurora, NY Elma, NY Lancaster, NY Cheektowaga, NY Buffalo, NY Tonawanda, NY
This is the structural argument, and it is an argument, not a quoted fact, so take it as the inference it is: a molecule this large and this complex, with no legitimate manufacturer and no reference standard, produced by the cheapest possible synthesis for an unregulated market, is close to impossible to make cleanly and impossible for the buyer to verify